Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mirco Di Marco"'
Autor:
Sagar Mahale, Meenakshi Setia, Bharat Prajapati, Santhilal Subhash, Mukesh Pratap Yadav, Subazini Thankaswamy Kosalai, Ananya Deshpande, Jagannath Kuchlyan, Mirco Di Marco, Fredrik Westerlund, L. Marcus Wilhelmsson, Chandrasekhar Kanduri, Meena Kanduri
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-20 (2022)
Using fibroblast growth factor 2 (FGF-2) induced sense and antisense transcripts IER3 and IER3-AS1 as a model system, authors highlight the role of HnRNPK in regulating double strand RNA formation in the loci with overlapping transcripts.
Externí odkaz:
https://doaj.org/article/411814645a2a43f093d137eb408eac1f
Autor:
Chandrasekhar Kanduri, Tanmoy Mondal, John Inge Johnsen, Matthias Fischer, Per Kogner, Maite Huarte, Leo Kurian, Ivan Raimondi, Santhilal Subhash, Daniel Jachimowicz, Silke Reischl, Subazini Thankaswamy Kosalai, Prasanna Kumar Juvvuna, Mirco Di Marco, Somsundar Veppil Muralidharan, Sanhita Mitra
Supplementary Text, Supplementary Table Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::008277634027dcc784f8bc3001f50e37
https://doi.org/10.1158/0008-5472.22425708.v1
https://doi.org/10.1158/0008-5472.22425708.v1
Autor:
Chandrasekhar Kanduri, Tanmoy Mondal, John Inge Johnsen, Matthias Fischer, Per Kogner, Maite Huarte, Leo Kurian, Ivan Raimondi, Santhilal Subhash, Daniel Jachimowicz, Silke Reischl, Subazini Thankaswamy Kosalai, Prasanna Kumar Juvvuna, Mirco Di Marco, Somsundar Veppil Muralidharan, Sanhita Mitra
Primers used in the current investigation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c2ea58a04ecaff9b536f62513ff6d74
https://doi.org/10.1158/0008-5472.22425702.v1
https://doi.org/10.1158/0008-5472.22425702.v1
Autor:
Chandrasekhar Kanduri, Tanmoy Mondal, John Inge Johnsen, Matthias Fischer, Per Kogner, Maite Huarte, Leo Kurian, Ivan Raimondi, Santhilal Subhash, Daniel Jachimowicz, Silke Reischl, Subazini Thankaswamy Kosalai, Prasanna Kumar Juvvuna, Mirco Di Marco, Somsundar Veppil Muralidharan, Sanhita Mitra
Neuroblastoma has a low mutation rate for the p53 gene. Alternative ways of p53 inactivation have been proposed in neuroblastoma, such as abnormal cytoplasmic accumulation of wild-type p53. However, mechanisms leading to p53 inactivation via cytoplas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23078e939f7b0d29d05e56d567d1d7b8
https://doi.org/10.1158/0008-5472.c.6512115
https://doi.org/10.1158/0008-5472.c.6512115
Autor:
Vittoria Carluccio, Antonella Maria Pia De Novellis, Martina Orlando, Paola Lanuti, Raffaele Bozzelli, Mirco Di Marco
Publikováno v:
Environmental Geochemistry and Health. 42:353-364
Medicinal mineral water, being provided by recognized immunosuppressive properties, results useful for treating many pathological conditions. A well-known source of sulfurous and oligomer medicinal mineral waters is located in Caramanico Terme (Pesca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::597c8ae03de0570cfd04d3e8bdc9dfae
https://doi.org/10.1007/s10653-019-00290-x
https://doi.org/10.1007/s10653-019-00290-x
Autor:
Mirco Di Marco, Meena Kanduri, Tanmoy Mondal, Subazini Thankaswamy Kosalai, Prasanna Kumar Juvvuna, Chandrasekhar Kanduri
Publikováno v:
Neuro-oncology Advances
Background MYCN has been an attractive therapeutic target in neuroblastoma considering the widespread amplification of the MYCN locus in neuroblastoma, and its established role in neuroblastoma development and progression. Thus, understanding neurobl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81103dd2800b1c0500d88466e47e7c85
http://europepmc.org/articles/PMC8156975
http://europepmc.org/articles/PMC8156975
Autor:
Idanna Innocenti, Rosa Visone, Mirco Di Marco, Mario Di Gioacchino, Felice Pepe, Manuela Iezzi, Barbara Vannata, Sara Pagotto, Marco Marchisio, Patrizia Di Gregorio, Paola Lanuti, Angelo Veronese, Sebastiano Miscia, Claudia Curcio, Alice Ramassone, Jonahunnatha Nesson George-William, Luigi Maria Larocca, Serena Veschi, Francesco Autore, Stefania Pacillo, Luca Laurenti, Renato Mariani-Costantini, Silvia Valentinuzzi
Publikováno v:
Cancers
Volume 13
Issue 2
Cancers, Vol 13, Iss 257, p 257 (2021)
Volume 13
Issue 2
Cancers, Vol 13, Iss 257, p 257 (2021)
The clinical progression of B cell chronic lymphocytic leukemia (CLL) is associated with immune cell dysfunction and a strong decrease of miR-181b-5p (miR-181b), promoting the death of CLL cells. Here we investigated whether the reduction of miR-181b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1bc455c886cf1cf727f436fc3da9a66
http://hdl.handle.net/10807/184584
http://hdl.handle.net/10807/184584
Autor:
Mirco, Di Marco, Serena, Veschi, Paola, Lanuti, Alice, Ramassone, Stefania, Pacillo, Sara, Pagotto, Felice, Pepe, Jonahunnatha Nesson, George-William, Claudia, Curcio, Marco, Marchisio, Sebastiano, Miscia, Idanna, Innocenti, Francesco, Autore, Barbara, Vannata, Patrizia, Di Gregorio, Mario, Di Gioacchino, Silvia, Valentinuzzi, Manuela, Iezzi, Renato, Mariani-Costantini, Luigi Maria, Larocca, Luca, Laurenti, Angelo, Veronese, Rosa, Visone
Publikováno v:
Cancers
Simple Summary Low expression of miR-181b in chronic lymphocytic leukemia (CLL) is linked to progression and cell death resistance. Patients with the progression of the disease show immune dysfunction. We aim at studying whether miR-181b is also invo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::93bfe5660e899a979115a2c6afbe8c42
https://pubmed.ncbi.nlm.nih.gov/33445508
https://pubmed.ncbi.nlm.nih.gov/33445508
Autor:
Silke Reischl, Mirco Di Marco, Catarina Darnfors, Kankadeb Mishra, Mohamad Moustafa Ali, Sagar Mahale, Chandrasekhar Kanduri, Meena Kanduri, Subazini Thankaswamy Kosalai, Luisa Statello, Daniel Jachimowicz
Publikováno v:
Oncogene. 40(13)
Recent advances in genomics unraveled several actionable mutational drivers in lung cancer, leading to promising therapies such as tyrosine kinase inhibitors and immune checkpoint inhibitors. However, the tumors' acquired resistance to the newly-deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae031d873196f276e6f126c5c0571e27
https://pubmed.ncbi.nlm.nih.gov/33674747
https://pubmed.ncbi.nlm.nih.gov/33674747
Autor:
Sanhita, Mitra, Somsundar Veppil, Muralidharan, Mirco, Di Marco, Prasanna Kumar, Juvvuna, Subazini Thankaswamy, Kosalai, Silke, Reischl, Daniel, Jachimowicz, Santhilal, Subhash, Ivan, Raimondi, Leo, Kurian, Maite, Huarte, Per, Kogner, Matthias, Fischer, John Inge, Johnsen, Tanmoy, Mondal, Chandrasekhar, Kanduri
Publikováno v:
Cancer research. 81(6)
Neuroblastoma has a low mutation rate for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91a7f81fb74ae81018b31a391a55c5ce
https://pubmed.ncbi.nlm.nih.gov/33372039
https://pubmed.ncbi.nlm.nih.gov/33372039